Abstract P6-10-01: Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomized, neoadjuvant phase-II study (ABCSG-34)CF Singer, G Michael, Herbert Stoeger et al.|Cancer Research|2017Cited by 2
Inhibition of the serine/threonine kinase BUB1 reverses taxane resistance in prostate cancerMartinez Maria Julia, Burnstein Kerry L, Lyles Rolando DZ et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0